Quantitative 1H NMR spectroscopic determination of the E/Z isomer ratio of the antidepressant drug fluvoxamine for use in pharmaceutical analysis

Magnetic Resonance in Chemistry

Volumn 40, Issue 12, 2002, Pages 762-766

  Deubner, Ralph ^a   Holzgrabe, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

1H NMR; E Z isomer ratio; Fluvoxamine; NMR; Oxime ethers; Quantitative NMR spectroscopy

Indexed keywords

ISOMERS; SPECTROSCOPIC ANALYSIS;

1H NMR; ANTIDEPRESSANT DRUG; E/Z ISOMER RATIO; E/Z ISOMERS; FLUVOXAMINE; ISOMER RATIOS; NMR-SPECTROSCOPY; OXIME ETHERS; QUANTITATIVE NMR SPECTROSCOPY; SPECTROSCOPIC DETERMINATIONS;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTIDEPRESSANT AGENT; FLUVOXAMINE; FLUVOXAMINE FUMARATE; FLUVOXAMINE MALEATE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; ISOMER; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

EID: 0038353672     PISSN: 07491581     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrc.1101     Document Type: Article

References (9)

1. Nelson JC. Biol. Psychiatry 1999; 46: 1301.
2. Anderson IM. J. Affective Disorders 2000; 58: 19.
3. Claasen V, Davies JE. Br. J. Pharmacol. 1997; 60: 505.
4. Dutch Patent NL 7503310 'Verbindingen met antidepressive werking', 1976; US Patent US 4085225 'Oxime ethers having anti-depressive activity', 1978.
5. Swiss Patent CH 691124 'Verfahren zu Herstellung von Fluvoxamin-Maleat', 2001.
6. British Pharmacopoeia 1998; Stationery Office, London.
7. (Draft monograph for the European Pharmacopoeia). Pharmaeuropa 2002; 14: 351.
8. Hilhorst MJ, Somsen GW, de Jong GJ. J. Pharm. Biomed. Anal. 1998; 16: 1251.
9. Diehl BWK, Holzgrabe U. In NMR Spectroscopy in Drug Development and Analysis, Holzgrabe U, Wawer I, Diehl BWK (ed.). Wiley-VCH: Weinheim, 1999; 82-101.